TP53突变预测扩散大B细胞淋巴瘤的预后不佳:一项单中心研究
Haiyan Zhang1,2, Xiang Zhang2,3,4,5, Jinghan Wang2,3,4,5
1Department of Oncology and Hematology, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, China.
Annals of hematology
|January 29, 2026
概括
TP53突变是扩散型大B细胞淋巴瘤 (DLBCL) 的显著预后因素,特别是在GCB亚型中. 将TP53突变与双表达淋巴瘤 (DEL) 结合起来,确定了针对性治疗的超高风险组.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 与复杂的基因组分类器相比,扩散型大B细胞淋巴瘤 (DLBCL) 中TP53突变的预后价值尚未完全理解.
- TP53突变与各种癌症有关,但它们在DLBCL亚型中的特定作用需要进一步阐明.
研究的目的:
- 研究TP53突变作为DLBCL中的预后生物标志物.
- 评估TP53突变对治疗反应和生存结果的影响.
- 探索 p53 免疫组织化学 (IHC) 分类器对预测TP53突变状态的有用性.
主要方法:
- 对444名新诊断的DLBCL患者进行了全面的基因组分析.
- 多变量分析以评估TP53突变的预后意义.
- 在TP53突变状态,治疗反应 (R-CHOP) 和临床结果 (OS,PFS) 之间的相关性分析.
- 一个p53 IHC分类系统的调整和验证.
主要成果:
- 在DLBCL患者中,TP53突变是较低整体存活率 (OS) 和无进展存活率 (PFS) 的独立预测因子 (P < 0.001).
- TP53突变的不良预后效应在生殖中心B细胞样 (GCB) 亚型中更为明显.
- 结合TP53突变和双表达淋巴瘤 (DEL),确定了一个超高风险组,生存率明显较差.
- 一个p53 IHC分类器在预测TP53突变状态方面表现出高灵敏度 (72.5%) 和特异性 (97.4%),表现优于常规切断值.
结论:
- TP53突变是DLBCL的一个关键的,上下文依赖的生物标志物.
- TP53突变和DEL的组合定义了一个临床可操作的超高风险子组.
- p53 IHC 分类器显示了作为DLBCL中TP53突变状态的快速和准确查工具的潜力.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
14.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.9K
Mutations
94.5K
Overview
94.5K
Mutations
44.5K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.5K
Diffusion
218.1K
Diffusion is the passive movement of substances down their concentration gradients—requiring no expenditure of cellular energy. Substances, such as molecules or ions, diffuse from an area of high concentration to an area of low concentration in the cytosol or across membranes. Eventually, the concentration will even out, with the substance moving randomly but causing no net change in concentration. Such a state is called dynamic equilibrium, which is essential for maintaining overall...
218.1K
Diffusion
6.4K
Diffusion is a type of passive transport. In passive transport, a substance tends to move from an area of high concentration to an area of low concentration until the concentration is equal across the space. For example, take the diffusion of substances through the air. When someone opens a perfume bottle in a room filled with people, the perfume is at its highest concentration in the bottle and is at its lowest at the edges of the room. The perfume vapor will diffuse, or spread away, from the...
6.4K
Viral Mutations
39.9K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K


